Effect of hydroxypropyl-β-cyclodextrin on the solubility, photostability and in-vitro permeability of alkannin/shikonin enantiomers

International Journal of Pharmaceutics

Volumn 141, Issue 1-2, 1996, Pages 171-178

  Chen, Chau Yang ^a   Chen, Fu An ^a   An Bang, Wu ^a   Hsu, Hsing Chu ^b   Kang, Jaw Jou ^c   Cheng, Hui Wen ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Alkannin shikonin enantiomers; Hydroxypropyl cyclodextrin; Permeability; Photostability; Solubility

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ALKANNIN; SHIKONIN;

ARTICLE; COMPLEX FORMATION; DIFFUSION; DRUG DECOMPOSITION; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; ENANTIOMER; OINTMENT; PHOTODEGRADATION; PRIORITY JOURNAL;

EID: 0030572642     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(96)04634-0     Document Type: Article

References (24)

1. Backensfeld, T., Müller, B.W., Wiese, M. and Seydel, J.K., Effect of cyclodextrin derivatives on indomethacin stability in aqueous solution. Pharm. Res., 7 (1990) 484-490.
2. Bekers, O., Uijtendaal, E.V., Beijnen, J.H., Bult, A. and Underberg, W.J.M., Cyclodextrins in the pharmaceutical field. Drug Dev. Ind. Pharm., 17 (1991a) 1503-1509.
3. Bekers, O., Beijnen, J.H., Vis, B.J., Suenaga, A., Otagiri, M., Bult, A. and Underberg, W.J.M., Effect of cyclodextrin complexation on the chemical stability of doxorubicin and daunorubicin in aqueous solution. Int. J. Pharm., 72 (1991b) 123-130.
4. Brewster, M.E., Loftsson, T., Estes, K.S., Lin, J.L., Friöriksdóttir, H. and Bodor, N., Effect of various cyclodextrin on solution stability and dissolution rate of doxorubicin hydrochloride. Int. J. Pharm., 19 (1992) 289-299.
5. Chen, F.A., Cheng, H.W., Wu, A.B., Hsu, H.C. and Chen, C.Y., Kinetic studies of the photochemical decomposition of alkannin shikonm enantiomers. Chem. Pharm. Bull., 44 (1996) 249-251.
6. Cheng, H.W., Chen, F.A., Hsu, H.C. and Chen, C.Y., Photochemical decomposition of alkannin/shikonin enantiomers. Int. J. Pharm., 120 (1995) 137-144.
7. Choudhury, S. and Nelson, K.F., Improvement of oral bioavailability of carbamazapine by inclusion in 2-hydroxypropyl-β-cyclodextrin. Int. J. Pharm., 85 (1992) 175-180.
8. Duchêne, D. and Wouessidjewe, D., Pharmaceutical uses of cyclodextrins and derivatives. Drug Dev. Ind. Pharm., 16 (1990) 2487-2499.
9. Frijlink, H.W., Bissens, A.C., Schoonen, A.J.M. and Lerk, C.F., The effects of cyclodextrin on drug release from fatty suppository bases, I. in vitro observations. Eur. J. Pharm. Biopharm., 37 (1991a) 178-182.
10. Frijlink, H.W., Eissens, A.C., Schoonen, A.J.M. and Lerk, C. F., The effects of cyclodextrin on drug release from fatty suppository bases. I. in vivo observations. Eur. J. Pharm. Biopharm., 37 (1991b) 183-187.
11. Hayashi, M., Pharmaceutical studies on crude plant drugs, Shikon and Tooki (II) shikonin and acetylshikonin. Folia Pharmacol. Jpn., 73 (1977) 193-203.
12. Higuchi, T. and Connors, K.A., Phase solubility techiniques. Anal. Chem. Instrum., 4 (1965) 117-212.
13. Higuchi, W.I., Diffusion models useful in biopharmaceutics drug release rate processes. J. Pharm. Sci., 56 (1967) 315-324.
14. Islam. M.S. and Narurkar, M.M., The effect of 2-hydroxypropyl-β-cyclodextrin on the solubility, stability and dissolution rate of famotidine. Drug Dev. Ind. Pharm., 17 (1991) 1229-1239.
15. Loftsson, T., Björnsdóttir, S., Pálsdóttir, G and Bodor, N., The effects of 2-hydroxypropyl-β-cyclodextrin on the solubility and stability of chlorambucil and melphalan in aqueous solution. Int. J. Pharm., 57 (1989) 63-72.
16. Loftsson, T., Friöriksdóttir, H. and Ólafsdóttir, B.J., Solubilization and stabilization of drugs through cyclodextrin complexation. Acta Pharm. Nord., 3 (1991) 215-217.
17. Müller, B.W. and Brauns, U., Solubilization of drugs by modified β-cyclodextrin. Int. J. Pharm., 26 (1985) 77-88.
18. Okamoto, H., Komatsu, H., Hashida, M. and Sezaki, H., Effect of β-cyclodextrin and di-O-methyl-β-cyclodextrin on the percutaneous absorption of butylparaben, indomethacin and sulfanilic acid. Int. J. Pharm., 30 (1986) 35-45.
19. Orienti, I., Valentino, A.F. and Zecchi, V., Inclusion complexes between non steroidal antiinflammatory drugs and β-cyclodextrin. Eur. J. Pharm. Biopharm., 37 (1991) 110-112.
20. Rahman, M.S., Babar, A., Patel, N.K. and Plakogiannis, F.M., Medicament release from ointment bases: V. naproxen in-vitro release and in-vivo percutaneous absorption in rabbits. Drug Dev. Ind. Pharm., 16 (1990) 651-672.
21. Sankawa, U., Ebizuka, Y., Miyazaki, T., Isomura, Y., Otsuka, H., Shibata, S., Inomata, M. and Fukuoka, F., Antitumor activity of shikonin and its derivatives. Chem. Pharm. Bull., 25 (1977) 2392-2395.
22. Seto, Y., Motoyoshi, S., Nakamura, H., Imuta, J., Ishitoku, T,. and Isayama, S., Effect of shikonin and its derivatives, pentaacetylated shikonin (MDS-004) on granuloma formation and delayed type allergy in experimental animals. Yakugaku Zasshi, 112 (1992) 259-271.
23. Tabata, M., Tsukada, M. and Fukui, H., Antimicrobial activity of quinone derivatives from Echium lycopsis callus cultures. Planta Med., 44 (1982) 234-236.
24. Takamoto, R., Namba, R., Nakata, O. and Sawada, T., In vitro percutaneous absorptiometry by simultaneous measurement using the photoacoustic method and absorbance. Anal. Chem., 62 (1990) 674-677.